Gromojung 1 mg (Finasteride)

Adult dose

Generally, finasteride is taken orally at a dosage of 1 mg once daily, and it can be taken regardless of meals. There is no evidence that increasing the dosage enhances its efficacy. Typically, it may take at least 3 months of continuous use to observe treatment effects, and ongoing intake is recommended to maintain treatment effects. The duration of treatment and efficacy should be continuously evaluated. If the medication is discontinued, the treatment effects will disappear within 12 months.

This medication should not be used by children or women. Women who are pregnant or may become pregnant should not handle broken pieces of this medication, as it can pose risks to the fetus if touched. During treatment, symptoms of depression or mood changes may occur; if these symptoms arise, immediate consultation with a doctor is necessary. Pregnant women should never take this medication as it may cause abnormalities in the development of the fetus's reproductive organs. Those allergic to this medication or currently taking similar medications should not use it. Patients with impaired liver function should use this medication cautiously. This medication may cause sexual dysfunction, such as decreased libido, erectile dysfunction, and ejaculatory disorders; if these symptoms occur, consult a doctor. If breast pain, enlargement or abnormal discharge occurs, notify a doctor immediately. This medication may affect the risk of prostate cancer, making regular check-ups with a doctor important. Interactions with other medications are minimal, but if you are taking other medications, be sure to inform your healthcare provider. Women who are pregnant or breastfeeding should not use this medication, and it is unknown if it passes into breast milk. The safety and efficacy in pediatric patients have not been established, so it should not be used in children. There is no need for dosage adjustment in the elderly, but the efficacy is not clearly established. Caution is required in interpreting blood test results while taking this medication. There is no specific treatment for overdose, but if unusual symptoms appear, visit a medical institution immediately. This medication should be stored out of reach of children and it is advisable not to transfer it to other containers. Long-term use has not reported carcinogenic risks, although rare cases of breast cancer have been documented. If sexual dysfunction occurs due to taking this medication, symptoms generally improve after discontinuation.

Serious side effects

• Hives, angioedema (including swelling of the lips, tongue, throat, and face) → severe allergic reaction
• Rash → severe skin reaction
• Severe rash accompanied by high fever, blisters, peeling skin, pain in oral/eye mucosa → severe skin reaction
• Difficulty breathing or respiratory issues, asthma attack, cough + fever accompanied respiratory issues → respiratory problems
• Yellowing of the skin or eyes (jaundice) along with elevated liver enzyme levels, systemic

Mild side effects

• Decreased libido
• erectile dysfunction
• ejaculatory disorder (reduced ejaculate)
• breast tenderness
• breast enlargement
• testicular pain
• hematuria
• dizziness
• headache
• palpitations

This medication should be stored in a tightly closed container to protect it from air and moisture, with a recommended storage temperature between 15 to 30 degrees Celsius. Proper storage maintains the medication's effectiveness and prevents degradation.

Appearance

Yellowish-brown film-coated tablets with a convex octagonal shape on both sides

Package unit

30 tablets/PTP [10 tablets × 3 PTP]